Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with gemcitabine, after cytoreductive surgery, may reduce the tumor progression of pancreatic cancer through the reduction of the neoplastic volume and the subpopulation of residual pancreatic cancer stem cells, improving the survival of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gastrointest Oncol
Päätekijät: Padilla-Valverde, David, García-Santos, Esther, Sanchez, Susana, Manzanares, Carmen, Rodriguez, Marta, González, Lucia, Ambrós, Alfonso, Cano, Juana M., Serrano, Leticia, Bodoque, Raquel, Vergara, Teresa, Martin, Jesus
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2021
Aiheet:
Original Article on Pancreas Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100727/
https://ncbi.nlm.nih.gov/pubmed/33968428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-238
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia